2025 American Academy of Neurology Abstract Website

Disclosures for "Super-Refractory Anti-NMDAR Encephalitis: Assessment of 43 Patients with Extremely Prolonged States of Minimal Consciousness"

Dr. Guasp has nothing to disclose.
Ms. Brenner has nothing to disclose.
Dr. dumez has nothing to disclose.
Dr. LaLive has nothing to disclose.
Ms. Wurdack has nothing to disclose.
Stefan Macher has nothing to disclose.
Dr. Wang has nothing to disclose.
Dr. Olivé has nothing to disclose.
Dr. Yeung has nothing to disclose.
Dr. Di Liberto has nothing to disclose.
Author has nothing to disclose
Dr. Zieglgaensberger has nothing to disclose.
Mamoru Shibata has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Japanese Headache Society. Mamoru Shibata has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Japanese Headache Society. Mamoru Shibata has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Japanese Society of Neurology. The institution of Mamoru Shibata has received research support from Otsuka Pharmaceutical Co. Ltd..
Dr. FUKAO has nothing to disclose.
Prof. Mishima has nothing to disclose.
Dr. Nakagawa has nothing to disclose.
Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Prof. Takizawa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Takizawa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teijin. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Daiichi Sankyo. Prof. Takizawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Prof. Takizawa has received research support from Eli Lilly. Prof. Takizawa has received research support from JSPS KAKENHI.
The institution of Dr. Shimohama has received research support from Grant-in-Aid for JSPS Fellows.
The institution of Dr. Izawa has received research support from Ministry of Education, Culture, Sports, Science and Technology (JAPAN).
Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Kurt-Wolfram Suhs has received research support from Bristol Myers Squibb.
Mr. Cabrera Maqueda has nothing to disclose.
Dr. Fonseca has nothing to disclose.
Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with Sanofi. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a speaker honoraria with Terumo. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with Janssen. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.
The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation.
Dr. Du Pasquier has nothing to disclose.
Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argen. The institution of Frank Leypoldt, MD has received research support from German Ministry of Research BMBF.
Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun and UCB Biopharma.
Carsten Finke, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myer Squibb. The institution of Carsten Finke, MD has received research support from Euroimmun.
Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received publishing royalties from a publication relating to health care.
Dr. Simabukuro has nothing to disclose.
The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology.
The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd.
Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.